Hsbc Holdings PLC Invests $648,000 in Cellebrite DI Ltd. (NASDAQ:CLBT)

Hsbc Holdings PLC purchased a new position in Cellebrite DI Ltd. (NASDAQ:CLBT - Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund purchased 74,834 shares of the company's stock, valued at approximately $648,000.

Several other hedge funds and other institutional investors have also made changes to their positions in the stock. Zurcher Kantonalbank Zurich Cantonalbank increased its holdings in shares of Cellebrite DI by 44.8% in the 3rd quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,091 shares of the company's stock worth $115,000 after buying an additional 4,672 shares during the last quarter. New York State Common Retirement Fund increased its stake in Cellebrite DI by 166.0% during the third quarter. New York State Common Retirement Fund now owns 15,440 shares of the company's stock worth $118,000 after acquiring an additional 9,635 shares during the last quarter. Barclays PLC raised its position in Cellebrite DI by 14.5% during the third quarter. Barclays PLC now owns 15,608 shares of the company's stock valued at $119,000 after purchasing an additional 1,982 shares during the period. Quantbot Technologies LP bought a new stake in shares of Cellebrite DI in the 3rd quarter valued at approximately $224,000. Finally, Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in shares of Cellebrite DI by 78.0% in the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 26,862 shares of the company's stock worth $233,000 after purchasing an additional 11,771 shares during the period. Institutional investors own 45.88% of the company's stock.

Cellebrite DI Trading Down 1.2 %

Shares of NASDAQ CLBT traded down $0.13 during trading hours on Friday, reaching $10.72. The stock had a trading volume of 319,999 shares, compared to its average volume of 643,243. Cellebrite DI Ltd. has a 52-week low of $5.22 and a 52-week high of $12.50. The firm has a market cap of $2.20 billion, a price-to-earnings ratio of -24.93, a P/E/G ratio of 1.91 and a beta of 1.51. The business's fifty day moving average price is $11.23 and its two-hundred day moving average price is $9.44.

Cellebrite DI (NASDAQ:CLBT - Get Free Report) last released its quarterly earnings data on Thursday, February 15th. The company reported $0.08 earnings per share for the quarter, beating the consensus estimate of $0.06 by $0.02. Cellebrite DI had a positive return on equity of 173.14% and a negative net margin of 24.94%. The firm had revenue of $93.01 million during the quarter, compared to the consensus estimate of $85.43 million. Equities research analysts anticipate that Cellebrite DI Ltd. will post 0.32 earnings per share for the current fiscal year.

Analyst Ratings Changes

CLBT has been the subject of a number of analyst reports. Bank of America raised their price target on Cellebrite DI from $12.00 to $13.00 and gave the stock a "buy" rating in a research report on Monday, April 1st. William Blair upgraded shares of Cellebrite DI from a "market perform" rating to an "outperform" rating in a report on Wednesday, March 13th. Craig Hallum raised their price objective on shares of Cellebrite DI from $14.00 to $16.00 and gave the stock a "buy" rating in a research note on Monday, April 1st. Lake Street Capital initiated coverage on Cellebrite DI in a research note on Friday, April 19th. They set a "buy" rating and a $13.00 target price on the stock. Finally, Needham & Company LLC boosted their price objective on Cellebrite DI from $13.00 to $13.50 and gave the company a "buy" rating in a report on Thursday, March 28th. Six analysts have rated the stock with a buy rating, According to MarketBeat, the company presently has an average rating of "Buy" and an average price target of $12.42.

Cellebrite DI Profile

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations in Europe, the Middle East, Africa, the Americas, and the Asia-Pacific. The company's DI suite of solutions allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations used in various cases, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, cryptocurrency, and intellectual property theft.